(New York, NY - March 1, 2023) - Sean Pinney, MD, FACC, FAST, FHFSA, a top expert in cardiovascular medicine and advanced heart failure and transplantation, has been named Chief of Cardiology at Mount Sinai Morningside. Dr. Pinney will lead all aspects of cardiology at the hospital, including the cardiac catheterization lab and the Al-Sabah Arrhythmia Institute.

Mount Sinai Morningside’s Division of Cardiology has gained national status over the past several years, including being named among the top 50 cardiology and cardiac surgery programs in the country by U.S. News & World Report. Dr. Pinney will build on this recognition and tradition of excellence in cardiac care at Mount Sinai Morningside.

“I’m thrilled to be returning to Mount Sinai Heart to build a cardiovascular center of excellence at Mount Sinai Morningside that serves the local communities of Harlem, Morningside Heights, and the Upper West Side, focusing on eliminating health care disparities and advancing the careers of our faculty, staff, and trainees,” says Dr. Pinney. “My vision is to create the top cardiovascular fellowship training program in New York and sustain a robust clinical trial program while employing the highest percentage of women and underrepresented minorities.”

Dr. Pinney rejoins Mount Sinai, where he served in many leadership roles from 2004 to 2020, including Director of Heart Failure and Transplantation for the Mount Sinai Health System, Fellowship Director of Advanced Heart Failure and Transplantation for The Mount Sinai Hospital, and Professor of Medicine for the Icahn School of Medicine at Mount Sinai. He most recently held leadership positions at the University of Chicago Medical Center, where he served as Director of Heart Failure and Cardiac Transplantation, Director of the Richard P. Parrillo Family Center for Clinical and Translational Cardiology Research, and Co-Director of the Heart and Vascular Center.

Dr. Pinney’s ongoing research focuses on innovative device therapies to treat heart failure and the investigation of novel immunosuppressive drugs for heart transplant recipients. He has published hundreds of book chapters, abstracts, and peer-reviewed papers in prestigious journals including Journal of the American College of Cardiology (JACC), JACC Heart Failure, Circulation, and The Journal of Heart and Lung Transplantation. Dr. Pinney is an associate editor of JACC and JACC Heart Failure, a contributing editor of ACCEL, and an editorial board member of the Journal of Heart Failure.

More People on the Move